November 17, 2019 / 4:39 PM / 21 days ago

BRIEF-Novartis Says Paragon-HF Analyses Suggest Entresto Benefit Beyond HFREF

Nov 17 (Reuters) - Novartis AG:

* NOVARTIS PARAGON-HF ANALYSES SUGGEST ENTRESTO® BENEFIT BEYOND HFREF

* NOVARTIS AG SAYS GREATER BENEFIT WAS SEEN IN WOMEN WITH HFPEF AND IN HFPEF PATIENTS RECENTLY HOSPITALIZED FOR HEART FAILURE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below